Long-term effects of pancreatic transplantation on diabetic neuropathy
Xavier Navarro MD, PhD
Department of Neurology, University of Minnesota, Minneapolis, MN
Department of Cell Biology and Physiology, Universitat Auto de Barcelona, Bellaterra, Spain
Search for more papers by this authorDavid E. R. Sutherland MD, PhD
Department of Surgery, University of Minnesota, Minneapolis, MN
Search for more papers by this authorCorresponding Author
Dr. William R. Kennedy MD
Department of Neurology, University of Minnesota, Minneapolis, MN
Department of Neurology, University of Minnesota, Box 187 UMHC, 420 Delaware St SE, Minneapolis, MN 55455Search for more papers by this authorXavier Navarro MD, PhD
Department of Neurology, University of Minnesota, Minneapolis, MN
Department of Cell Biology and Physiology, Universitat Auto de Barcelona, Bellaterra, Spain
Search for more papers by this authorDavid E. R. Sutherland MD, PhD
Department of Surgery, University of Minnesota, Minneapolis, MN
Search for more papers by this authorCorresponding Author
Dr. William R. Kennedy MD
Department of Neurology, University of Minnesota, Minneapolis, MN
Department of Neurology, University of Minnesota, Box 187 UMHC, 420 Delaware St SE, Minneapolis, MN 55455Search for more papers by this authorAbstract
Restoration of a long-lasting euglycemic state by a functioning pancreatic transplantation (PTx) is the most logical treatment for insulin-dependent diabetes mellitus and for amelioration of secondary complications, including neuropathy. We evaluated neurological function by clinical examination, nerve conduction studies, and autonomic function tests in 115 patients with a functioning PTx and in 92 control patients treated with insulin, at baseline and 1, 2, 3.5, 5, 7, and 10 years later. In control patients, neuropathy progressively worsened during follow-up. The clinical examination score and composite indices of abnormality of motor and sensory nerve conduction decreased significantly at all intervals tested. Autonomic function indices also decreased, but significantly only after 1 year. In patients who received a successful PTx the neuropathy improved. The motor and sensory nerve conduction indices increased significantly at all intervals after transplantation, whereas the clinical examination and autonomic tests improved only slightly. Patients who received either a PTx alone, a PTx after a kidney graft, or simultaneous pancreatic and kidney transplantations improved similarly over the follow-up. These results indicate that a functioning PTx halts the progression and improves the signs of diabetic polyneuropathy by restoration of a normoglycemic state.
References
- 1 PJ Dyck, PK Thomas, AK Asbury, et al, eds. Diabetic neuropathy. Philadelphia: WB Saunders, 1987
- 2
Pirart J.
Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973.
Diabetes Care
1978;
1: 168–188
10.2337/diacare.1.3.168 Google Scholar
- 3 Brown MJ, Asbury AK. Diabetic neuropathy. Ann Neurol 1984; 15: 2–12
- 4 Amthor K-F, Dahl-Jørgensen K, Berg TJ, et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia 1994; 37: 579–584
- 5 Stephenson J, Fuller JH. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study. Diabetologia 1994; 37: 278–285
- 6
Gregersen G.
Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.
Diabetologia
1968;
4: 273–277
10.1007/BF01309900 Google Scholar
- 7 Halar EM, Graf RJ, Halter JB, et al. Diabetic neuropathy: a clinical, laboratory and electrodiagnostic study. Arch Phys Med Rehab 1982; 63: 298–303
- 8 Holman RR, Mayon-White V, Orde-Peckar C, et al. Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients: a two year randomized prospective study. Lancet 1983; 1: 204–208
- 9 Fedele D, Negrin P, Cardone C, et al. Influence of continuous subcutaneous insulin infusion (CSII) treatment on diabetic somatic and autonomic neuropathy. J Endocrinol Invest 1984; 7: 623–628
- 10 Service FJ, Rizza RA, Daube JR, et al. Near normoglycemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 1985; 28: 722–727
- 11 Dahl-Jørgensen K, Brinchmann-Hansen O, Hanssen KF, et al. Effect of near normoglycaemia on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J 1986; 293: 1195–1199
- 12 Ehle AL, Raskin P. Increased nerve conduction in diabetics after a year of improved glucoregulation. J Neurol Sci 1986; 74: 191–197
- 13 Krönert K, Hülser J, Luft D, et al. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction. J Clin Endocrinol Metab 1987; 64: 1219–1223
- 14 Judzewitsch RG, Jaspan JB, Polonsky KS, et al. Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N Engl J Med 1983; 308: 119–125
- 15 Jaspan J, Herold K, Bartkus C. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy. Am J Med 1985; 79: 24–37
- 16 Pfeifer MA. Effects of glycemic control and aldose reductase inhibition on nerve conduction velocity. Am J Med 1985; 79 (suppl 5A): 18–23
- 17 Sima AAF, Bril V, Nathaniel V, et al. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med 1988; 319: 548–555
- 18 Sorbinil Retinopathy Trial Research Group. The Sorbinil Retinopathy Trial: neuropathy results. Neurology 1993; 43: 1141–1149
- 19 Santiago JV, Sönsken PH, Boulton AJM, et al. Withdrawal of the aldose reductase inhibitor Tolrestat in patients with diabetic neuropathy: effect on nerve function. J Diabetic Complications 1993; 7: 170–178
- 20 Reichard P, Nilsson B-Y, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993; 329: 304–309
- 21 Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986
- 22 Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol 1995; 38: 869–880
- 23 Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122: 561–568
- 24 Unger RH. Meticulous control of diabetes: benefits, risks and precautions. Diabetes 1982; 31: 479–483
- 25 Committee on Health Care Issues. Does improved control of glycaemia prevent or ameliorate diabetic polyneuropathy? Ann Neurol 1986; 19: 288–290
- 26 Ziegler D, Dannehl K, Wiefels K, Gries FA. Differential effects of near-normoglycaemia for 4 years on somatic nerve dysfunction and heart rate variation in type 1 diabetic patients. Diabetes Med 1992; 9: 622–629
- 27 Kennedy WR, Navarro X, Goetz FC, et al. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031–1037
- 28 Vial C, Martin X, Lefrancois N, et al. Sequential electrodiagnostic evaluation of diabetic neuropathy after combined pancreatic and renal transplantation. Diabetologia 1991; 34: S100–S102
- 29 Solders G, Tydén G, Persson A, Groth CG. Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes 1992; 41: 946–951
- 30 Müller-Felber W, Landgraf R, Sheuer R, et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993; 42: 1482–1486
- 31 Trojaborg W, Smith T, Jakobsen J, Rasmussen K. Effect of pancreas and kidney transplantation on the neuropathic profile in insulin-dependent diabetes with end-stage nephropathy. Acta Neurol Scand 1994; 90: 5–9
- 32 Pyke DA. Pancreas transplantation. Diabetes Metab Rev 1991; 7: 3–14
- 33 Robertson RP. Pancreas transplantation in humans with diabetes mellitus. Diabetes 1991; 40: 1085–1089
- 34 Remuzzi G, Ruggenenti P, Mauer SM. Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 1994; 343: 27–31
- 35 Sutherland DER, Goetz FC, Najarian JS. Pancreas transplantation at the University of Minnesota: donor and recipient selection, operative and postoperative management, and outcome. Transplant Proc 1987; 19 (suppl 4): 63–74
- 36 Sutherland DER, Dunn DL, Goetz FC, et al. A 10-year experience with 290 pancreas transplants at a single institution. Ann Surg 1989; 210: 274–288
- 37 Sutherland DER, Gruessner RWG, Gores PF, et al. Pancreas transplantation: an update. Diabetes Metab Rev 1995; 11: 337–363
- 38 Morel P, Goetz FC, Moudry-Munns KC, et al. Long-term glucose control in patients with pancreatic transplants. Ann Intern Med 1991; 115: 694–699
- 39 Kennedy WR, Navarro X, Sutherland DER. Neuropathy profile of diabetic patients in a pancreas transplantation program. Neurology 1995; 45: 773–780
- 40 Kennedy WR, Navarro X, Sakuta M, et al. Physiological and clinical correlates of cardiorespiratory reflexes in diabetes mellitus. Diabetes Care 1989; 12: 399–408
- 41 Kennedy WR, Navarro X. Sympathetic sudomotor function in diabetic neuropathy. Arch Neurol 1989; 46: 1182–1186
- 42 Solders G, Anderson T, Borin Y, et al. Electroneurography index: a standardized neurophysiological method to assess peripheral nerve function in patients with polyneuropathy. Muscle Nerve 1993; 16: 941–946
- 43 Peripheral Nerve Society. Diabetic polyneuropathy in controlled clinical trials: consensus report of the Peripheral Nerve Society. Ann Neurol 1995; 38: 478–482
- 44
Dyck PJ,
O'Brien PC.
Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy.
Diabetes Care
1989;
12: 649–652
10.1002/mus.880110106 Google Scholar
- 45 Van der Vliet JA, Navarro X, Kennedy WR, et al. The effect of pancreas transplantation on diabetic polyneuropathy. Transplantation 1988; 45: 368–370
- 46 Landgraf R, Nusser J, Müller W, et al. Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation. Diabetes 1989; 38 (suppl 1): 33–37
- 47 Comi G, Galardi G, Amadio S, et al. Neurophysiological study of the effect of combined kidney and pancreas transplantation on diabetic neuropathy: a 2-year follow-up evaluation. Diabetologia 1991; 34: S103–S107
- 48 Sutherland DER, Kendall DM, Moudry KC, et al. Pancreas transplantation in nonuremic, type I diabetic recipients. Surgery 1988; 104: 453–464
- 49 Solders G, Wilczek H, Gunnarsson R, et al. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: a two-year follow-up study. Lancet 1987; 2: 1232–1235
- 50 Solders G, Tydén G, Tibell A, et al. Improvement in nerve conduction 8 years after combined pancreatic and renal transplantation. Transplant Proc 1995; 27: 3091
- 51 Nusser J, Scheuer R, Abendroth A, et al. Effect of pancreatic and/or renal transplantation on diabetic autonomic neuropathy. Diabetologia 1991; 34: S118–S120
- 52 Gaber AC, Hathaway DK, Abell T, et al. Improved autonomic and gastric function in pancreas-kidney vs kidney-alone transplantation contributes to quality of life. Transplant Proc 1994; 26: 515–516
- 53 Pfeifer MA, Schumer MP. Clinical trials of diabetic neuropathy: past, present, and future. Diabetes 1995; 44: 1355–1361
- 54 Bolinder J, Wahrenberg H, Linde B, et al. Improved glucose counterregulation after pancreas transplantation in diabetic patients with unawareness of hypoglycemia. Transplant Proc 1991; 1667–1669
- 55 Van der Vliet JA, Navarro X, Kennedy WR, et al. Long term follow-up of polyneuropathy in diabetic kidney transplant recipients. Diabetes 1988; 37: 1247–1252
- 56 Kennedy WR, Navarro X, Sutherland DER. Small nerve fiber neuropathy in diabetes mellitus after pancreas transplantation. Muscle Nerve 1989; 9: 767–768
- 57 Johansson B-L, Borg K, Fernqvist-orbes E, et al. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996; 39: 687–695
- 58 Bohman SO, Wilczek H, Tyden G, et al. Recurrent diabetic neuropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 1987; 19: 2290–2293
- 59 Bilous RW, Mauer SM, Sutherland DER, et al. The effects of pancreas transplantation on the glomerular structure of renal allografts in patients with insulin-dependent diabetes. N Engl J Med 1989; 321: 80–85
- 60 Wilczek H, Jaremko G, Tydén G, Groth CG. Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 1995; 59: 51–57
- 61 Fioretto P, Mauer SM, Bilous RW, et al. Effects of pancreas transplantation on glomerular structure in insulin-dependent diabetic patients with their own kidneys. Lancet 1993; 342: 1193–1196
- 62 Abendroth D, Landgraf R, Illner WD, Land W. Evidence for reversibility of diabetic microangiopathy following pancreas transplantation. Transplant Proc 1989; 21: 2850–2851
- 63 Cheung ATW, Perez RV, Basadonna GP, et al. Microangiopathy reversal in successful simultaneous pancreas-kidney transplantation. Transplant Proc 1994; 26: 493–495
- 64 Ramsay RC, Goetz FC, Sutherland DER, et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 208–214
- 65 Wang Q, Klein R, Moss SE, et al. The influence of combined pancreas-kidney transplantation on the progression of diabetic retinopathy: a case series. Ophthalmology 1994; 101: 1071–1076
- 66 Gross CR, Zehrer CL. Health-related quality of life outcomes of pancreas transplant recipients. Clin Transplant 1992; 6: 165–171
- 67 Zehrer CL, Gross CR. Comparison of quality of life between pancreas/kidney and kidney transplant recipients: 1-year followup. Transplant Proc 1994; 26: 508–509
- 68 Nakache R, Tyden G, Groth CG. Long-term quality of life in diabetic patients after combined pancreas-kidney transplantation or kidney transplantation. Transplant Proc 1994; 26: 510–511
- 69 Navarro X, Kennedy WR, Loewensen RB, Sutherland DER. Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 1990; 39: 802–806
- 70
Navarro X,
Kennedy WR,
Aeppli D,
Sutherland DER.
Neuropathy and mortality in diabetes: influence of pancreas transplantation.
Muscle Nerve
1996;
19: 1009–1016
10.1002/(SICI)1097-4598(199608)19:8<1009::AID-MUS9>3.0.CO;2-4 CAS PubMed Web of Science® Google Scholar